Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review

1 of 4

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • GenMark Diagnostics Inc
  • Luminex Corp
  • Pacific Biosciences Inc
  • Qiagen NV
  • MORE
Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

Illumina Inc Key Recent Developments

Apr 24, 2018: Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
Mar 12, 2018: Illumina Names Dr. Phil Febbo Chief Medical Officer
Feb 12, 2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
Jan 30, 2018: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • GenMark Diagnostics Inc
  • Luminex Corp
  • Pacific Biosciences Inc
  • Qiagen NV
  • MORE
Section 1 - About the Company
  • Illumina Inc - Key Facts
  • Illumina Inc - Key Employees
  • Illumina Inc - Key Employee Biographies
  • Illumina Inc - Major Products and Services
  • Illumina Inc - History
  • Illumina Inc - Company Statement
  • Illumina Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Illumina Inc - Business Description
  • Product Category: Consumables
  • Overview
  • Performance
  • Product Category: Instruments
  • Overview
  • Performance
  • Product Category: Services and Others
  • Overview
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other Markets
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Illumina Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Illumina Inc - Strengths
  • Illumina Inc - Weaknesses
  • Illumina Inc - Opportunities
  • Illumina Inc - Threats
  • Illumina Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Illumina Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Illumina Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Illumina Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 24, 2018: Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
  • Mar 12, 2018: Illumina Names Dr. Phil Febbo Chief Medical Officer
  • Feb 12, 2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
  • Jan 30, 2018: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
  • Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
  • Dec 11, 2017: Illumina Names Aimee Hoyt Chief People Officer, Bringing 20+ Years of Senior Human Resources Leadership from Global Technology Companies
  • Nov 08, 2017: Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare
  • Oct 24, 2017: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2017
  • Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017
  • Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Illumina Inc, Key Facts
  • Illumina Inc, Key Employees
  • Illumina Inc, Key Employee Biographies
  • Illumina Inc, Major Products and Services
  • Illumina Inc, History
  • Illumina Inc, Other Locations
  • Illumina Inc, Subsidiaries
  • Illumina Inc, Joint Venture
  • Illumina Inc, Key Competitors
  • Illumina Inc, Ratios based on current share price
  • Illumina Inc, Annual Ratios
  • Illumina Inc, Annual Ratios
  • Illumina Inc, Annual Ratios
  • Illumina Inc, Interim Ratios
  • Illumina Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Illumina Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Illumina Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Illumina Inc, Performance Chart (2013 - 2017)
  • Illumina Inc, Ratio Charts
  • Illumina Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Illumina Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific Inc
  • Roche Diagnostics International Ltd
  • Qiagen NV
  • Pacific Biosciences Inc
  • Oxford Nanopore Technologies Ltd
  • Luminex Corp
  • GenMark Diagnostics Inc
  • Agilent Technologies Inc
  • Affymetrix, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll